iLite® ADCC Effector FcγRIIIa (V)


iLite® ADCC Effector FcγRIIIa (V) Assay Ready Cells are used for quantifying biological activity induced by pathway activation of therapeutic antibody drugs in an ADCC mechanism of action (MOA) assay.

The cells are based on a human T lymphocyte cell line, Jurkat (ATCC #TIB-152), and have been genetically engineered and optimized to express high levels of the low affinity Fc receptor FcRyIIIa (CD16), and the Firefly Luciferase (FL) reporter gene under the control of a proprietary chimeric promoter.

iLite® ADCC Effector FcγRIIIa (V) Assay Ready Cells are ideally matched to the iLite® ADCC target cells but can be run with any type of target cells inducing ADCC MOA.

The ATCC® TIB-152 cell line is used under a license from ATCC®


Add to cart    
iLite® ADCC Effector (V)

At a glance

Product code BM5001
Assay target ADCC
Size 1 vial corresponding to one 96 well plate
Read-out of results Quantitative,
Detection system Luminescence
Regulatory status Research Use Only

What's in the box?

>250 µL of iLite® Assay Ready Cells suspended in cryoprotective medium from Gibco (cat no 12648-010).


More content

Get access to scientific material, posters and more.

More downloads